Ron Squarer
2014
In 2014, Ron Squarer earned a total compensation of $2.2M as Chief Executive Officer at Array BioPharma, a 8% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $341,825 |
|---|---|
| Option Awards | $1,237,019 |
| Salary | $548,750 |
| Other | $62,675 |
| Total | $2,190,269 |
Squarer received $1.2M in option awards, accounting for 56% of the total pay in 2014.
Squarer also received $341.8K in non-equity incentive plan, $548.8K in salary and $62.7K in other compensation.
Rankings
In 2014, Ron Squarer's compensation ranked 4,162nd out of 13,032 executives tracked by ExecPay. In other words, Squarer earned more than 68.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,162 out of 13,032 | 68th |
Division Manufacturing | 1,470 out of 4,966 | 70th |
Major group Chemicals And Allied Products | 475 out of 1,686 | 72nd |
Industry group Drugs | 367 out of 1,365 | 73rd |
Industry Pharmaceutical Preparations | 293 out of 1,043 | 72nd |
Source: SEC filing on September 12, 2016.
Squarer's colleagues
We found three more compensation records of executives who worked with Ron Squarer at Array BioPharma in 2014.